Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 28189904 | HLA MATCHED (HLA-MATCHED) | peripheral blood stem cell transplantation | NA | mycophenolate | NA | unclassified | |
| the hematopoietic cell transplantation comorbidity index (hct-ci) has been validated as a tool for evaluating the risk of treatment-related mortality (trm) in hla-matched sibling and matched unrelated donor bone marrow and peripheral blood stem cell transplantation patients. | |||||||
| 28446305 | HLA (HLA) | peripheral blood stem cell transplantation | NA | NA | NA | unclassified | |
| this study provides experimental evidence for clinical application of hla haploidentical peripheral blood stem cell transplantation from double donors. | |||||||
| 28592758 | HLA MISMATCHED (HLA-MISMATCHED) | cyclophosphamide | NA | fludarabine | NA | unclassified | |
| NA | |||||||
| 29779324 | HLA MATCHED (HLA-MATCHED) | peripheral blood stem cell transplantation | NA | methotrexate | NA | unclassified | |
| objective: to explore the effectiveness of a novel gvhd prophylaxis regimen containing low-dose anti-t lymphocyte globulin (atg) in patients undergoing peripheral blood stem cell transplantation (pbsct) from hla-matched sibling donors (msd) given both the patients and donors were aged over forty years old. | |||||||
| 30087460 | HLA (HLA) | peripheral blood stem cell transplantation | NA | cyclophosphamide | NA | negative | |
| myeloablative and reduced-intensity conditioning in hla-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide. | |||||||
| 30087460 | HLA (HLA) | peripheral blood stem cell transplantation | NA | cyclophosphamide | NA | negative | |
| we conducted two parallel prospective, multicenter, phase ii studies to evaluate the safety and efficacy of hla-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide (ptcy-haplopbsct) following myeloablative conditioning (mac, n = 50) and reduced-intensity conditioning (ric, n = 77). | |||||||
| 30951841 | HLA (HLA) | cyclophosphamide | NA | fludarabine | NA | unclassified | |
| NA | |||||||
| 32624582 | HLA MATCHED (HLA-MATCHED) | peripheral blood stem cell transplantation | NA | NA | NA | unclassified | |
| low-dose anti-thymocyte globulin for gvhd prophylaxis in hla-matched allogeneic peripheral blood stem cell transplantation. | |||||||
| 32973350 | HLA (HLA) | cyclophosphamide | NA | tacrolimus | NA | negative | |
| NA | |||||||
| 32973350 | HLA (HLA) | cyclophosphamide | NA | tacrolimus | NA | negative | |
| NA | |||||||
Copyright 2024